Douglas Earl Martin insider trades

Douglas Earl Martin has filed 7 Form 4s with the SEC that we hold, all for Allogene Therapeutics, Inc. (ALLO), as SVP, General Counsel. Across all of them we count 0 purchases worth $0 and 3 sales worth $114.2K reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($103.3K). The largest single trade was a sale of 29,697 shares of Allogene Therapeutics, Inc. worth $63.0K, dated 2026-08-21. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2023-08-17 and the latest 2026-08-25.

Allogene Therapeutics, Inc. (ALLO)

SVP, General Counsel · 7 filings · 3 purchases and sales

Trade date	Code	Shares	Value as filed	Filed	Source
2025-02-03	S, sale reported on Form 4	6,404	$11.0K	2025-02-05	SEC
2026-02-02	S, sale reported on Form 4	22,900	$40.3K	2026-02-04	SEC
2026-08-21	S, sale reported on Form 4	29,697	$63.0K	2026-08-25	SEC

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1362155) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-28 · For informational purposes only, not investment advice.
Privacy · Terms